chemotherapy

You have access
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI

Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
You have access
Snail Mucus Enhances Chemosensitivity of Triple-negative Breast Cancer Via Activation of the Fas Pathway
CHIEN-YI HO, DAI-WEI HU, BO-RONG CHEN, CHUN-CHUN YANG, CHUN-HSU YAO, TIEN NI, WEI-CHUAN HO, YUEH-SHENG CHEN, CHIH-YEN TU, WEI-CHAO CHANG, YANG-CHANG WU, CHIH-HSIN TANG, HUI-CHI HUANG, WEI-CHIEN HUANG and TZONG-SHIUN LI

Anticancer Research February 2022, 42 (2) 845-855; DOI: https://doi.org/10.21873/anticanres.15542
You have access
ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer
TAKAHIRO YOSHIDA, TAKESHI NISHINO, MASAKAZU GOTO, SEIYA INOUE, SATOSHI FUJIWARA, HIROMITSU TAKIZAWA, AKIRA TANGOKU, HISANORI UEHARA and YOSHIMI BANDO

Anticancer Research January 2022, 42 (1) 195-203; DOI: https://doi.org/10.21873/anticanres.15473
You have access
Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
You have access
Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes
DONIKA IVANOVA, ZHIVKO ZHELEV, GENOVEVA ZLATEVA, DESSISLAVA LAZAROVA, ZVEZDELINA YANEVA, RADMILA PANOVSKA, ICHIO AOKI and RUMIANA BAKALOVA

Anticancer Research January 2022, 42 (1) 547-554; DOI: https://doi.org/10.21873/anticanres.15512
You have access
Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review
XIAOFENG ZENG, LIYING ZHANG, SHULI JIA, TAIPING LIN, GONGXIANG LIU, JIRONG YUE and XIAOLI HUANG

Anticancer Research December 2021, 41 (12) 5903-5912; DOI: https://doi.org/10.21873/anticanres.15409
You have access
Effect of Monoammonium Glycyrrhizinate on the Development of Hepatotoxicity After Initial Intrathecal Chemotherapy for Leukemia
KENJI KISHIMOTO, DAIICHIRO HASEGAWA, SUGURU UEMURA, SAYAKA NAKAMURA, AIKO KOZAKI, ATSURO SAITO, TOSHIAKI ISHIDA, TAKESHI MORI and YOSHIYUKI KOSAKA

Anticancer Research December 2021, 41 (12) 6231-6236; DOI: https://doi.org/10.21873/anticanres.15443
You have access
Applicability of the Histoculture Drug Response Assay to Predict Platinum Sensitivity and Prognosis in Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research December 2021, 41 (12) 6287-6292; DOI: https://doi.org/10.21873/anticanres.15450
You have access
Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases
TOMOYA TAGO, KENJI KATSUMATA, RYUTARO UDOU, KENTA KASAHARA, JUNICHI MAZAKI, HIROSHI KUWABARA, MASANOBU ENOMOTO, TETSUO ISHIZAKI, YUICHI NAGAKAWA, KATSUTOSHI SUGIMOTO, TAKAO ITOI and AKIHIKO TSUCHIDA

Anticancer Research November 2021, 41 (11) 5539-5547; DOI: https://doi.org/10.21873/anticanres.15367
You have access
Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research October 2021, 41 (10) 4673-4685; DOI: https://doi.org/10.21873/anticanres.15281

Main menu

User menu

Search

chemotherapy

Pages